Home > Specialists > Gastrointestinal Surgery > Dr. Xiaowen Liu (刘晓文)
Specialty & Clinical Focus:
Gastric cancer surgeon and Chief Physician at Fudan University Shanghai Cancer Center in Shanghai, specializing in laparoscopic and robotic gastrectomy, multidisciplinary care, and the management of locally advanced gastric cancer.
Professional Title & Qualifications:
-
Chief Physician
-
MD
-
PhD
-
Associate Professor
Hospital & Department：
Fudan University Shanghai Cancer Center – Department of Gastric Surgery
(address: No. 270 Dong'an Road, Xuhui District, Shanghai, 200032)
Dr. Xiaowen Liu (刘晓文) - Surgical Oncologist
Personal Biography
Dr. Xiaowen Liu is a Chief Physician and Associate Professor in the Department of Gastric Surgery at Fudan University Shanghai Cancer Center. His clinical work focuses on gastric cancer surgery, including laparoscopic and robotic gastrectomy, multidisciplinary management, and locally advanced gastric cancer. He holds MD and PhD qualifications and contributes to gastrointestinal oncology research on perioperative treatment strategies, tumour biology, and the tumour microenvironment. Dr. Liu is also a member of the hospital’s Gastric Cancer Multidisciplinary Team.
Why Choose Dr. Xiaowen Liu for Your Care?
Dr. Xiaowen Liu is a Chief Physician and Associate Professor in the Department of Gastric Surgery at Fudan University Shanghai Cancer Center. With more than two decades of surgical oncology experience, his clinical work focuses on gastric cancer, including laparoscopic and robotic gastrectomy, multidisciplinary care, and the management of locally advanced disease. For international patients comparing treatment options in Shanghai, this focused background is particularly relevant when seeking a structured specialist review before travel.
Dr. Liu’s involvement in the Gastric Cancer MDT and his experience with perioperative chemoradiotherapy and conversion strategies may be valuable for cases requiring coordinated input across surgery, oncology, radiology, and pathology. Reviewing pathology, imaging, previous treatment and a clear question list in advance can help patients prepare more effectively for discussions about possible next steps. His visiting-scholar experience at Duke University Medical Center also adds an international academic perspective to his work in gastric oncology.
Pre-Travel Case Review & Specialist Liaison
International patients considering gastric cancer care in Shanghai benefit from organizing their records and questions before committing to travel. A pre-travel specialist review can clarify the information required by the hospital, the issues to discuss, and the practical next steps for an in-person pathway.
MedBridgeNZ coordinates medical-record preparation, translation, client-authorized document transfer and appointment communication with Dr. Liu’s hospital team. Once the remote review has been confirmed, Dr. Liu will review the submitted records, provide his specialist opinion and recommendations, and respond to the patient’s prepared questions.
The resulting feedback can help patients identify any additional documents or tests requested by the hospital and plan the timing and logistics of travel to China more confidently.
Disclaimer: MedBridgeNZ is a medical concierge provider serving a global client base. We assist with logistical coordination and facilitate access to healthcare professionals. MedBridgeNZ does not provide medical advice, diagnoses, or treatments.Any clinical feedback, treatment planning or suitability discussion remains with the relevant hospital or licensed specialist.
Secure a Remote Case Review with
Dr. Xiaowen Liu
Areas of Expertise
Surgical treatment of gastric cancer (stomach cancer)
Minimally invasive surgery, including laparoscopic and robotic gastrectomy
Comprehensive multidisciplinary treatment (MDT) for gastric cancer
Management of locally advanced gastric cancer (LAGC)
Perioperative chemotherapy and chemoradiotherapy
Diagnosis and treatment of gastric linitis plastica
Verified Client Satisfaction Metrics
⭐⭐⭐⭐⭐ 5.0/5.0 Overall Rating
* Treatment Pathway Satisfaction:
5.0/5.0
* Communication & Professionalism:
5.0/5.0
* High demand: Chosen online for specialist liaison and case reviews by over:
4,100 clients
(Source: These third-party platform indicators are provided for general reference only. They may change over time and should not be interpreted as a guarantee of diagnosis, treatment suitability, appointment availability, or individual clinical outcome.)
Work Experience
Chief Physician, Department of Gastric Surgery, Fudan University Shanghai Cancer Center, Shanghai, China
Associate Professor, Fudan University Shanghai Cancer Center
Medical practitioner specializing in abdominal surgery and gastric cancer oncology at Fudan University Shanghai Cancer Center
Education & Training
Awards & Honors
Academic & Professional Memberships
Member of the Multidisciplinary Team (MDT) for Gastric Cancer at Fudan University Shanghai Cancer Center
Reviewer and contributor to oncology journals, including Frontiers in Oncology
Research & Publications
Principal Investigator/Contact for the PREACT Study (Chemoradiotherapy vs. Chemotherapy Followed by D2 Surgery for Locally Advanced Gastric Cancer)
Published research on the prognostic significance of tumor markers in gastric cancer
Conducted studies on the role of cancer-associated fibroblasts (CAF) in the tumor microenvironment of gastric cancer
Research on epithelial-mesenchymal transition (EMT) signatures for predicting prognosis and immunotherapy response in gastric cancer
Authored publications in journals including Oncotarget and Pharmacological Research
Selected Peer-Reviewed Publications
Selected peer-reviewed publications relevant to Dr. Liu’s clinical and research focus:
Liu X, et al. Preoperative Chemoradiotherapy versus Chemotherapy for Locally Advanced Gastric Cancer or Gastroesophageal Junction Adenocarcinoma: A Phase III Randomized Controlled Trial from China. Cancer Commun (Lond). 2026;46:0006. PMID: 41625476
Song J, et al. Antigen-presenting cancer associated fibroblasts enhance antitumor immunity and predict immunotherapy response. Nat Commun. 2025;16(1):2175. PMID: 40038297
Liu X, et al. Phase II trial of preoperative chemoradiation plus perioperative SOX chemotherapy in patients with locally advanced gastric cancer. J Surg Oncol. 2018;117(4):692–698. PMID: 29194623
*The doctor’s information is sourced from the hospital’s official website or provided directly by the doctor. Due to update cycles, there may be occasional delays in reflecting the most recent changes.
Frequently Asked Questions (FAQs)
Can Dr. Xiaowen Liu review my stage of gastric cancer before I travel to Shanghai?
Dr. Liu’s practice covers gastric cancer surgery from early-stage minimally invasive procedures to multidisciplinary and conversion strategies for locally advanced disease. Suitability depends on the pathology, imaging, disease stage, previous treatment and overall clinical context. MedBridgeNZ coordinates record preparation, translation and client-authorized transfer for a confirmed remote specialist review. Once the review is confirmed, Dr. Liu will review the submitted materials, provide his specialist opinion and recommendations, and address the patient’s prepared questions before an in-person pathway is arranged.
How can the Gastric Cancer MDT at Fudan Cancer Center inform my treatment pathway?
For complex or locally advanced gastric cancer, treatment discussions may involve surgery, perioperative chemotherapy, chemoradiotherapy, imaging, pathology and medical oncology input. Dr. Liu is a member of the Gastric Cancer MDT at Fudan University Shanghai Cancer Center. An MDT-informed specialist opinion can help explain how these components may fit together, identify information that still needs to be collected, and give patients a clearer framework for discussing the next stage of care with the hospital team.
How do international patients request a remote specialist review or hospital appointment with Dr. Liu?
Start by submitting the available pathology, imaging reports, treatment history and key questions to MedBridgeNZ. We coordinate record organization, translation, client-authorized document transfer and communication with Dr. Liu’s hospital team. After the remote review is confirmed and completed, we can assist with an onsite appointment request where available, medical invitation or visa-document coordination support, travel planning, and non-clinical bilingual administrative support in China. Appointment timing remains subject to the hospital’s scheduling process.
Flexible Ways to Connect with the Specialist
We understand that every client’s situation is unique. Beyond the Remote Written Review, we offer a range of flexible ways to access specialist insights:
-
Remote Video Liaison: For a more personal interaction, we can arrange a live video session, allowing you to discuss your case directly with the specialist with the help of our professional medical translators.
-
On-Site Proxy Liaison: If you cannot travel, our dedicated bilingual team can visit the hospital in person on your behalf. We will present your translated medical records to the specialist, facilitate your inquiries, and provide you with a comprehensive translated report of the doctor’s findings.
-
In-Person Appointment Booking: If you are planning to travel to China for treatment, we manage the complex hospital registration and appointment process, ensuring you have confirmed access to your chosen specialist upon arrival.
How MedBridgeNZ Helps You:
MedBridgeNZ is a New Zealand-based medical concierge and logistics coordination provider for international patients exploring specialist care in China. We assist with appointment request coordination, medical-record preparation, translation coordination, client-authorized document transfer, medical invitation or visa-document support, travel planning, and non-clinical bilingual administrative support. We do not provide medical advice, diagnosis or treatment; all clinical opinions and decisions are made independently by the relevant licensed specialist or hospital. Hospital, specialist and other third-party costs remain separate from MedBridgeNZ coordination fees unless expressly stated in writing.